Upharmacia April 2017
immunoglobulin will be subjected to laboratory analysis ( in terms of quality to ensure efficiency and safety ).
5 . In case the Draft is adopted , the laboratory analysis will also be conducted if for the last 2 years circulation of other series of medicinal products was banned , regardless of whether they were removed from circulation or not . Let us remind you that under the current Procedure the reason enough for laboratory analysis is a ban on circulation of medicinal products of other series ( regardless of the period or the date of its introduction ), which were withdrawn from circulation in due course .
6 . It prescribed to cancel the requirement to obtain a conclusion on the same series of medicinal products on the following conditions : if series of medicinal product were imported as one batch for various commercial entities , are stored in one customs warehouse , ( if necessary ) with a positive laboratory test results of quality of samples taken from one of them . In this case , it is proposed to control such series of medicinal product only visually .
HEALTHCARE NEWS
The Reimbursement System was Launched
On Apr 1 , the governmental program “ Affordable drugs ” was officially launched in Ukraine . The program allows patients to receive certain drugs against cardiovascular diseases , asthma and diabetes for free or with surcharge . According to Vice Prime Minister of Ukraine , as on Apr 20 , 2700 pharmacies throughout Ukraine joined the program , while their number is expected to grow . As on Apr 27 , about 48 ths people in Kyiv used the program . The average cost of the prescription amounted UAH 40 .
The PM of Ukraine said that the government could increase the funding of the program in 2017 by UAH 250 mio . Initially , UAH 500 mio were allocated for the program in 2017 , which is only half of the minimum needed , according to estimates . The list of medicines , which fall under reimbursement , could also be expanded .
International Clinical Protocols will be used in Ukraine
The MOH approved the Order , which would allow Ukrainian physicians using international clinical protocols in providing medical aid since May 2017 . However , additional time will be needed to translate and approve the protocols . The acting Head of the MOH stated that the Order would allow to publicly procure more modern and effective medicines . The Order is permissive in nature , so physicians will choose between national and international protocols .
The Deputy Head of the MOH
Olexandr Linchevskiy stated that the use of international protocols would stimulate pharmaceutical companies to register new medicines in Ukraine . “ If the producer sees , that clinical protocol , which foresees the use of a specific preparation , works in Ukraine , he will expand its portfolio ,” Mr . Linchevskiy said .
MOH and NABU will Fight Corruption in Healthcare
On 28 Apr , the MOH signed Memorandum on cooperation with NABU ( National Anti- Corruption Bureau of Ukraine ) to form the basis of systematic cooperation in fight against corruption in the health sector .
“ We want the civil society to start making regular screenings on the ground to prevent corruption crimes ,” the acting Head of the MOH Ulana Suprun
8 www . upharma-c . com